Rapid Influenza Diagnostic Tests Market Size, Share & Forecast by 2034

Coverage: By Test Type (Influenza A Tests, Influenza B Test, and Influenza A+B Test); Sample Type (Nasal Swab, Throat Swab, Nasopharyngeal Swab, and Others); Technology [Immunochromatographic Assays, Immunofluorescence Assays, and Nucleic Acid Amplification Test (NAAT)]; End User (Hospitals and Clinics, Diagnostic Centers, Nursing Homes, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00017827
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : April 17, 2026
Rapid Influenza Diagnostic Tests Market Size, Share & Forecast by 2034
Report Date: April 17, 2026   |   Report Code: TIPRE00017827 Email: sales@theinsightpartners.com

2025 Market Size

US$ 1,457.31 Mn

Base year value

2034 Forecast

US$ 2,332.49 Mn

Projected by 2034

CAGR 2026-2034

5.37 %

Growth rate

Addressable Market

US$ 17,192.26 Mn

(2026-2034)

The global rapid influenza diagnostic tests market size is projected to reach US$ 2,332.49 million by 2034 from US$ 1,457.31 million in 2025. The market is anticipated to register a CAGR of 5.37% during the forecast period 2026-2034.

The report is segmented by Type (Hydraulic, Manual, Electronic). The report further presents analysis based on the Application (Dental Laboratory, Hospital, Others). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Rapid Influenza Diagnostic Tests Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Rapid Influenza Diagnostic Tests Market Segmentation Test Type

  1. Influenza A Tests
  2. Influenza B Test
  3. Influenza A+B Test

Sample Type

  1. Nasal Swab
  2. Throat Swab
  3. Nasopharyngeal Swab
  4. Others

Technology

  1. Immunochromatographic Assays
  2. Immunofluorescence Assays
  3. Nucleic Acid Amplification Test

End User

  1. Hospitals and Clinics
  2. Diagnostic Centers
  3. Nursing Homes
  4. Others

Market Assessment and Insights

  • Global market for Rapid Influenza Diagnostic Tests was valued at US$ 1,457.31 Million in 2025
  • Annual market size is expected to reach US$ 2,332.49 Million by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 17,192.26 Million
  • Market is anticipated to register a CAGR of 5.37% during the forecast period
  • The United States represents a key market, supported by Rising cases of influenza, Technological Advancements, Increased Awareness and Access, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Emerging Markets, Combination Tests Development, Investment on R&D are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including DiaSorin S.p.A, Becton Dickinson and Company, SA Scientific, CorisBioconcep, Meridian Bioscience Inc., Abbott, Analytik Jena, Roche, Quidel Corporation, Princeton BioMeditech Corporation, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Rapid Influenza Diagnostic Tests Market: Strategic Insights

rapid-influenza-diagnostic-tests-ridt-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Rapid Influenza Diagnostic Tests Market Growth Drivers

  1. Rising cases of influenza: The growing prevalence of influenza infections, especially the seasonal outbreaks contribute to the increasing demand for its rapid diagnostic tests. Early and effective treatments of the infection are also needed; accordingly, rapid influenza diagnostic tests have become a key tool that healthcare providers have adopted to improve patient outcomes and improve clinical workflows.
  2. Technological Advancements: Development in the field of diagnostics, for example, improved, and user-friendly rapid influenza tests, are helping enhance the growth of the market. The advancement leads to quicker results, it is more sensitive, and thus a must-have in clinical and point-of-care settings, with more and more healthcare professionals being on board.
  3. Increased Awareness and Access: More patient and provider awareness about the importance of early diagnosis of influenza-the primary reason for market growth. More access through retail pharmacies and clinics, ensuring rapid testing, makes their use more likely and enhances public health responses during flu seasons.

Rapid Influenza Diagnostic Tests Market Future Trends

  1. Point-of-Care Testing: The rapid influenza diagnostic tests market goes forward with point-of-care testing. Convenience and speed have been driving healthcare providers to adopt POC tests so that results obtained instantly help them make treatment decisions immediately and can improve patient care as well as resource management in a clinical setting.
  2. Integration into the Digital Health Trend: Rapid diagnostic tests are increasingly being introduced with digital health technologies, such as mobile applications and telemedicine. It addresses better management of data; remote consultations are taken care of through the integration of medical consultations with patients; it is efficient in monitoring cases of influenza; and overall, it enhances healthcare delivery and engages patients.
  3. The role of increased government initiative: Increased governmental activities in funding and awareness campaigns boost the usage of rapid influenza diagnostic tests. Such increased initiatives enhance surveillance and control over outbreaks of the flu, hence encouraging the development and delivery of these tests in all public and private facilities.

Rapid Influenza Diagnostic Tests Market Opportunities

  1. Emerging Markets: Rapidly growing healthcare infrastructure in the emerging markets opens vast opportunities for rapid influenza diagnostic tests. More investments by regions in improving healthcare create rising demand for such effective diagnostic tools, opening scope for manufacturers to tap into new markets and customers.
  2. Combination Tests Development: The combination tests would enable manufacturers to devise tests which can detect more than one agent responsible for respiratory illness, such as influenza, at the same time. Therefore, this innovation would solve a problem for healthcare providers of having broad and comprehensive testing solutions most desired in an outbreak of respiratory illness.
  3. Investment on R&D: Newer advanced technologies meant for diagnostics research will attract more investments in R&D. Thus, they can open up new avenues in the rapid influenza diagnostic tests market, focusing more on the precision, quick detection, and easy handling of tests results for the attraction of healthcare providers to provide better public health management at the time of flu seasons.

Rapid Influenza Diagnostic Tests Market Report Scope

Report Attribute Details
Market size in 2025 US$ 1,457.31 Million
Market Size by 2034 US$ 2,332.49 Million
Global CAGR (2026 - 2034) 5.37%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Test Type
  • Influenza A Tests
  • Influenza B Test
  • Influenza A+B Test
By Sample Type
  • Nasal Swab
  • Throat Swab
  • Nasopharyngeal Swab
  • Others
By Technology
  • Immunochromatographic Assays
  • Immunofluorescence Assays
  • Nucleic Acid Amplification Test
By End User
  • Hospitals and Clinics
  • Diagnostic Centers
  • Nursing Homes
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • DiaSorin S.p.A
  • Becton Dickinson and Company
  • SA Scientific
  • CorisBioconcep
  • Meridian Bioscience Inc.
  • Abbott
  • Analytik Jena
  • Roche
  • Quidel Corporation
  • Princeton BioMeditech Corporation

Rapid Influenza Diagnostic Tests Market Players Density: Understanding Its Impact on Business Dynamics

The Rapid Influenza Diagnostic Tests Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

rapid-influenza-diagnostic-tests-ridt-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Rapid Influenza Diagnostic Tests Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Rapid Influenza Diagnostic Tests Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

The rapid influenza diagnostic tests market is estimated to grow with a CAGR of 5.36% from 2026 to 2034

Asia-Pacific region is likely to witness the fastest growth rate during the forecast period

The market drivers include rising prevalence of influenza infections and innovations in diagnostic technology are driving the rapid influenza diagnostic tests market.

The rapid influenza diagnostic tests market majorly consists of players such as DiaSorin S.p.A, Becton Dickinson and Company, SA Scientific among others.

Shift towards point-of-care (POC) testing is a significant trend in the rapid influenza diagnostic tests market is likely to remain the key trend during the forecast period.

North America dominated the rapid influenza diagnostic tests market in 2025.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA